ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,246.68
0.48%
US Tech 100
17,844.80
0.69%
다우존스 지수
39,558.11
0.32%
Bitcoin
61,546.85
-2.16%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Redhill Biopharma Ltd (RDHL)

  7. Redhill Biopharma Ltd (RDHL) 뉴스

RDHL

Redhill Biopharma (RDHL)

Redhill Biopharma Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:RDHL
일자시간출처헤드라인심볼기업
2024/05/0620:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
2024/05/0620:00PR Newswire (US)RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035NASDAQ:RDHLRedhill Biopharma Ltd
2024/04/2420:00PR Newswire (US)RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 StudyNASDAQ:RDHLRedhill Biopharma Ltd
2024/04/0822:23PR Newswire (US)RedHill Biopharma Announces Full-Year 2023 Results and Operational HighlightsNASDAQ:RDHLRedhill Biopharma Ltd
2024/04/0220:00PR Newswire (US)RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market PriceNASDAQ:RDHLRedhill Biopharma Ltd
2024/03/1120:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
2024/03/1120:00PR Newswire (US)RedHill Announces New USPTO Patent Covering Talicia® Through 2034NASDAQ:RDHLRedhill Biopharma Ltd
2024/03/0521:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
2024/03/0521:00PR Newswire (US)RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures ProgramsNASDAQ:RDHLRedhill Biopharma Ltd
2024/02/2106:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
2024/02/2021:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
2024/02/2021:00PR Newswire (US)RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New PublicationNASDAQ:RDHLRedhill Biopharma Ltd
2024/02/1622:54Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RDHLRedhill Biopharma Ltd
2024/02/1614:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RDHLRedhill Biopharma Ltd
2024/02/1406:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
2024/02/0522:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RDHLRedhill Biopharma Ltd
2024/02/0306:10Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:RDHLRedhill Biopharma Ltd
2024/02/0200:22Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:RDHLRedhill Biopharma Ltd
2024/01/2702:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
2024/01/2702:46PR Newswire (US)RedHill Biopharma Announces Closing of $8 Million Registered Direct OfferingNASDAQ:RDHLRedhill Biopharma Ltd
2024/01/2623:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
2024/01/2623:29Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RDHLRedhill Biopharma Ltd
2024/01/2523:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
2024/01/2523:05PR Newswire (US)RedHill Biopharma Announces $8 Million Registered Direct OfferingNASDAQ:RDHLRedhill Biopharma Ltd
2024/01/2520:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
2024/01/2520:00PR Newswire (US)RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042NASDAQ:RDHLRedhill Biopharma Ltd
2023/12/2022:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
2023/12/2022:45PR Newswire (US)RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against EbolaNASDAQ:RDHLRedhill Biopharma Ltd
2023/12/1221:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
2023/12/1221:00PR Newswire (US)RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:RDHLRedhill Biopharma Ltd
 검색 관련기사 보기:NASDAQ:RDHL

최근 히스토리

EU
IEGOV
Amundi EGOV iNav
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유